Santen Pharmaceutical , Ltd. Other Current Liabilities

Santen Pharmaceutical , Ltd. (SNPHF) currently reports a other current liabilities of $51B as of June 2026. That compares with $44B in the prior-year period — up 14.6% year over year. Use the charts on this page to explore Santen Pharmaceutical , Ltd.'s other current liabilities history and peer comparisons.

Santen Pharmaceutical , Ltd.'s other current liabilities increased from $44B to $51B — a 14.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Santen Pharmaceutical , Ltd. reported $51B in other current liabilities as of June 2026. That compares with $44B in the prior-year period — up 14.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $51B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Santen Pharmaceutical , Ltd., and consider following SNPHF for alerts when major investors trade the stock.